Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFG-02 transdermal patch proof-of-concept study in underactive bladder
jRCT2071260068Recruiting
- Sponsor
- Juro Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Detrusor hypocontractility comparing SFG-02 transdermal patch with Matching placebo transdermal patch (2 arms). Primary endpoint: Change in bladder voiding efficiency from baseline to Week 12. Started Aug 2026; status: recruiting.
02
Drugs
SFG-02
03
Conditions
Detrusor hypocontractility
Beyond the preview
Go deeper on jRCT2071260068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260068.